BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31008542)

  • 1. Fetal echocardiographic prediction score for perinatal mortality in tricuspid valve dysplasia and Ebstein's anomaly.
    Torigoe F; Ishida H; Ishii Y; Ishii R; Narita J; Kawazu Y; Kayatani F; Inamura N
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):226-232. PubMed ID: 31008542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-gestation prediction of outcome in tricuspid valve dysplasia and Ebstein's anomaly using fetal tricuspid regurgitation waveform analysis.
    Ikegawa T; Kim KS; Kawataki M; Ichikawa Y; Ono S; Yanagi S; Ueda H
    Ultrasound Obstet Gynecol; 2023 May; 61(5):593-600. PubMed ID: 36273401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebstein's anomaly and tricuspid valve dysplasia: prognosis after diagnosis in utero.
    Barre E; Durand I; Hazelzet T; David N
    Pediatr Cardiol; 2012 Dec; 33(8):1391-6. PubMed ID: 22639000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perinatal course of Ebstein's anomaly and tricuspid valve dysplasia in the fetus.
    Lasa JJ; Tian ZY; Guo R; Rychik J
    Prenat Diagn; 2012 Mar; 32(3):245-51. PubMed ID: 22430722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Assessment of Left Ventricular Dysfunction in Fetal Ebstein's Anomaly and Tricuspid Valve Dysplasia.
    Eckersley LG; Howley LW; van der Velde ME; Khoo NS; Mah K; Brooks P; Colen T; Hornberger LK
    J Am Soc Echocardiogr; 2019 Dec; 32(12):1598-1607. PubMed ID: 31551185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Perinatal Mortality in Ebstein's Anomaly Diagnosed in the Second Trimester of Pregnancy.
    Masoller N; Gómez Del Rincón O; Herraiz I; Gómez-Montes E; Soveral I; Pérez-Cruz M; Martínez-Biosques C; Granados MA; Bennasar M; Escobar-Diaz MC; Martínez JM; Galindo A
    Fetal Diagn Ther; 2020; 47(8):604-614. PubMed ID: 32018269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular function and geometry in fetuses with severe tricuspid regurgitation.
    Ishii T; Tworetzky W; Harrild DM; Marcus EN; McElhinney DB
    Ultrasound Obstet Gynecol; 2012 Jul; 40(1):55-61. PubMed ID: 21997973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary Outcomes and Factors Associated With Mortality After a Fetal or Neonatal Diagnosis of Ebstein Anomaly and Tricuspid Valve Disease.
    Wertaschnigg D; Manlhiot C; Jaeggi M; Seed M; Dragulescu A; Schwartz SM; van Arsdell G; Jaeggi ET
    Can J Cardiol; 2016 Dec; 32(12):1500-1506. PubMed ID: 27476984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and Predictors of Perinatal Mortality in Fetuses With Ebstein Anomaly or Tricuspid Valve Dysplasia in the Current Era: A Multicenter Study.
    Freud LR; Escobar-Diaz MC; Kalish BT; Komarlu R; Puchalski MD; Jaeggi ET; Szwast AL; Freire G; Levasseur SM; Kavanaugh-McHugh A; Michelfelder EC; Moon-Grady AJ; Donofrio MT; Howley LW; Tierney ES; Cuneo BF; Morris SA; Pruetz JD; van der Velde ME; Kovalchin JP; Ikemba CM; Vernon MM; Samai C; Satou GM; Gotteiner NL; Phoon CK; Silverman NH; McElhinney DB; Tworetzky W
    Circulation; 2015 Aug; 132(6):481-9. PubMed ID: 26059011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Progressive Pathophysiology After Early Prenatal Diagnosis of the Ebstein Anomaly or Tricuspid Valve Dysplasia.
    Selamet Tierney ES; McElhinney DB; Freud LR; Tworetzky W; Cuneo BF; Escobar-Diaz MC; Ikemba C; Kalish BT; Komarlu R; Levasseur SM; Puchalski MD; Satou GM; Silverman NH; Moon-Grady AJ
    Am J Cardiol; 2017 Jan; 119(1):106-111. PubMed ID: 27793395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Ventricular Dysfunction in Neonatal Ebstein's Anomaly and Tricuspid Valve Dysplasia.
    Teramachi Y; Hornberger LK; Howley L; van der Velde ME; Eckersley LG
    J Am Soc Echocardiogr; 2022 May; 35(5):503-512.e3. PubMed ID: 35093556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Neonatal Intervention on Left Ventricular Performance in Ebstein's Anomaly and Tricuspid Valve Dysplasia.
    Teramachi Y; Hornberger LK; Howley L; van der Velde ME; Al-Aklabi M; Eckersley LG
    J Am Soc Echocardiogr; 2024 Feb; 37(2):248-254. PubMed ID: 38013061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the prognosis of Ebstein's anomaly during fetal life.
    Pavlova M; Fouron JC; Drblik SP; van Doesburg NH; Bigras JL; Smallhorn J; Harder J; Robertson M
    Am Heart J; 1998 Jun; 135(6 Pt 1):1081-5. PubMed ID: 9630115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of In Utero Non-Steroidal Anti-Inflammatory Drug Therapy for Severe Ebstein Anomaly or Tricuspid Valve Dysplasia (NSAID Therapy for Fetal Ebstein anomaly).
    Freud LR; Wilkins-Haug LE; Beroukhim RS; LaFranchi T; Phoon CK; Glickstein JS; Cumbermack KM; Makhoul M; Morris SA; Sun HY; Ferrer Q; Pedra SR; Tworetzky W
    Am J Cardiol; 2021 Feb; 141():106-112. PubMed ID: 33217351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracardiac Doppler indices predict perinatal mortality in fetuses with Ebstein anomaly and tricuspid valve dysplasia.
    Wang S; Freud LR; Detterich J; Moon-Grady AJ; Donofrio MT; Jaeggi ET; Szwast AL; Morris SA; Kavanaugh-Mchugh A; Howley LW; van der Velde ME; Cuneo BF; Phoon CK; Tworetzky W; Pruetz JD
    Prenat Diagn; 2021 Feb; 41(3):332-340. PubMed ID: 33242215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association of Pulmonary Flow Characteristics With Cardiac Function in Tricuspid Valve Malformation Fetuses: Study With Two-Dimensional Speckle Tracking Echocardiography.
    Liu J; Cao H; Cui L; Zhang Y; Song X; Ma J; Shi J; Zhang L; Hong L; Xie M
    J Ultrasound Med; 2022 Jul; 41(7):1791-1805. PubMed ID: 34726794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of prenatal haemodynamic and functional abnormalities in Ebstein's anomaly on survival.
    Freire G; Nguyen T; Sekar P; Wilhm M; Arnold K; Leshko J; Amankwah EK; Huhta J
    Cardiol Young; 2014 Dec; 24(6):1049-56. PubMed ID: 25647378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Mortality and Circulatory Outcome Among Neonates Prenatally Diagnosed With Ebstein Anomaly or Tricuspid Valve Dysplasia: A Multicenter Study.
    Freud LR; McElhinney DB; Kalish BT; Escobar-Diaz MC; Komarlu R; Puchalski MD; Jaeggi ET; Szwast AL; Freire G; Levasseur SM; Kavanaugh-McHugh A; Michelfelder EC; Moon-Grady AJ; Donofrio MT; Howley LW; Selamet Tierney ES; Cuneo BF; Morris SA; Pruetz JD; van der Velde ME; Kovalchin JP; Ikemba CM; Vernon MM; Samai C; Satou GM; Gotteiner NL; Phoon CK; Silverman NH; Tworetzky W
    J Am Heart Assoc; 2020 Nov; 9(21):e016684. PubMed ID: 33076749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular myocardial performance in the fetus with severe tricuspid valve disease and tricuspid insufficiency.
    Inamura N; Taketazu M; Smallhorn JF; Hornberger LK
    Am J Perinatol; 2005 Feb; 22(2):91-7. PubMed ID: 15731988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricuspid valve disease with significant tricuspid insufficiency in the fetus: diagnosis and outcome.
    Hornberger LK; Sahn DJ; Kleinman CS; Copel JA; Reed KL
    J Am Coll Cardiol; 1991 Jan; 17(1):167-73. PubMed ID: 1987222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.